Cite

HARVARD Citation

    Kaplan, J. et al. (n.d.). Predicting resistance to dasatinib therapy for patients with Philadelphia-positive leukemia with prior tyrosine kinase inhibitor failure. Leukemia & lymphoma. 56 (7), pp. 1922-1923. [Online]. 
  
Back to record